300485.SZ
赛升药业
SZSE · Healthcare · C 制造业 · CN
CNY 9.05
−8.68%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
68.5x
Market Cap
CNY 4.36B
MomentumView details →
1D Return
−8.68%
YTD Return
−18.34%
RSI (14)
39.4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
68.5x
Market Cap
CNY 4.36B
RSI (14)
39.4
MomentumView details →
1D Return
−8.68%
YTD Return
−18.34%
Similar companies
Latest newsMore news →
Beijing Saisheng Pharmaceutical Co., Ltd. obtained a new drug production license from the Beijing Municipal Drug Administration, adding a new production site for three ganglioside sodium injection products.11d agoBeijing Saisheng Pharmaceutical announced its first-half 2026 results: revenue fell 8.17% year-on-year to 181 million yuan, and net loss attributable to shareholders was 144 million yuan, down 400.66% year-on-year.13d ago